共 46 条
- [1] Atkinson K(1991)A prospective randomised trial of cyclosporin and methotrexate vs cyclosporin, methotrexate and prednisolone for prevention of graft-vs-host disease after HLA-identical sibling marrow transplantation for haematological malignancy Aust N Z J Med 21 850-856
- [2] Biggs J(2000)Equivalence of 2 effective graft-vs-host disease prophylaxis regimens: results of a prospective double-blind randomized trial Biol Blood Marrow Transplant 6 254-261
- [3] Concannon A(1997)Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-vs-host disease: a prospective, randomized trial Blood 89 3880-3887
- [4] Dodds A(2000)Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-vs-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study Blood 96 2391-2398
- [5] Young S(1990)What role for prednisone in prevention of acute graft-vs-host disease in patients undergoing marrow transplants? Blood 76 1037-1045
- [6] Wilson F(2000)Cyclosporine (CSP) or CSP plus methylprednisolone for graft-vs-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial Blood 96 1194-1195
- [7] Chao NJ(2003)Cyclosporine, methotrexate and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-vs-host disease in bone marrow transplantation from HLA-identical sibling donor: long-term follow-up of a randomized study (abstract) Bone Marrow Transplant 31 S138-1332
- [8] Snyder DS(1994)Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-vs-host disease prevention Blood 84 1328-undefined
- [9] Jain M(undefined)undefined undefined undefined undefined-undefined
- [10] Wong RM(undefined)undefined undefined undefined undefined-undefined